Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

SBC Medical Group Holdings Q3 2026 Results: Net Income $15.7M, Up 22.4% YoY

SBC Medical Group Holdings reported total revenues of $150.8 million for the nine months ended September 30, 2026, a 12.5% increase year-over-year. Net income for the same period rose to $38.9 million, driven by strong performance in related party revenues and improved operational efficiency.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue58.643.4
Gross profit42.230.6
Profit before tax26.418.5
Net income15.712.8
EPS (diluted, $ a share)$0.15$0.12

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+22.4%
Revenue, year on year+35.1%
Gross margin72.0%
Operating margin45.1%
Source

10-Q filed with the SEC, NASDAQ: SBC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

SBC Medical Group Holdings Inc: key numbers

Share price
$6.18Close, Nov 16
Market cap
$636M
Shares outstanding
102.85MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Offices & Clinics of Doctors of MedicineSIC 8011

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from SBC Medical Group Holdings Inc

All →
6:50 AM ET 8-K
Financial Results

SBC Medical Group Holdings Financial Results

SBC Medical Group reported third quarter 2026 revenue of $59 million, a 35% increase year-over-year, driven by service fee revisions and clinic network expansion. Net income attributable to the company rose 22% to $16 million, while Adjusted EBITDA grew 66% to $28 million. The company's supported clinic network expanded to 293 locations, representing a year-over-year increase of 36 locations.

Term
Q3 2026

“The third quarter of 2026 marked a strong reacceleration in SBC Medical’s growth. Revenue increased 35% year-over-year, income from operations rose 66%, and net income attributable to SBC Medical rose 22%, with a net income margin of 27% and an Adjusted EBITDA margin of 47%.”

Yoshiyuki Aikawa, Chairman and CEO

“Our MSO revenue growth is supported by two key levers: expanding our clinic network and increasing service fees per clinic. Our goal is not simply to add locations. We aim to raise productivity and profitability at the clinics we support while expanding the network efficiently.”

Yoshiyuki Aikawa, Chairman and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.